FDA approves Phibro's new fish antibiotic
The US Food and Drug Administration (FDA) has approved a new antibiotic, PAQFLOR, for use with finfish. PAQFLOR, a broad-spectrum antibiotic in the form of a 50% (500 g/Kg) florfenicol premix, is produced by Phibro Animal Health Corporation (Phibro). It is designed for use with freshwater-reared salmonids, catfish, freshwater-reared finfish and warmwater finfish.
Mike Brown, Vice President of Mineral Nutrition & Aqua, North America, said: “We are excited to further support the US aquaculture industry’s efforts to reach its production and sustainability goals by bringing to market a proven, cost-effective, florfenicol antimicrobial product. We share our customers’ commitment to improving productivity through good health management practices. By bringing PAQFLOR to market Phibro is giving producers more health management options.”
Todd Armstrong, President, North America, said: “Having a new aquaculture product in the US allows Phibro to continue our mission of providing safe and effective solutions for our customers’ unique health challenges.”
You May Also Like
Sign up to our daily Newsletters
Permission Statement
Yes! I would like to be sent emails from Fish Farmer Magazine
I understand that my personal information will not be shared with any third parties, and will only be used to provide me with useful targeted articles as indicated.
I'm also aware that I can un-subscribe at any point either from each email notification or on My Account screen.
© 2025 Fish Farmer.